CARVIDOMET

$0.00

Dosage form:

  • Tablets
  • Modified release tablets

Composition:

  • Each film coated tablet contains: Trimetazidine HCL 20 mg
  • Each modified release film coated tablet contains: Trimetazidine HCL 35 mg

Description

Indication:

Add on therapy for symptomatic treatment of patients with: stable angina and heart failure

Contraindications:

  • Hypersensitivity to any of drug components
  • Parkinson disease, tremor, restless leg syndrome
  • Sever renal impairment (creatinine clearance < 30ml/min)
  • Pregnancy and lactation.

Side Effects:

Dizziness, headache, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, rash, pruritus, urticarial and asthenia.

Dosage and Administration:

1 tablet 20 mg 3 times a day or 1 tablet 35 mg twice daily during meals.

Renal impairment: If creatinine clearance 30-60 ml/min, the recommended dose is 1 tablet 20 mg twice daily or 1 XR tablet in the morning.

How Supplied:

  • CARVIDOMET 20 mg: boxes of 30 or 60 film coated tablets.

CARVIDOMET 35 mg: boxes of 30 or 60 film coated tablets.